Skip to content
DataLookout
Menu

University of Cambridge clinical trial pipeline

Get alerts when University of Cambridge's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable: PIILL · PET Imaging of Inflammation and Lipid Lowering Study Primary completion date changed from estimate of Oct 1, 2025 to May 30, 2026 University of CambridgeNot applicable NCT04073797
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-11-03 NCT07913919 Effect of Anifrolumab on Arterial Inflammation in Systemic Lupus Erythematosus Study Recruiting

Active trials by phase

Phase 2
1
Not charted: 21 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 12

Get alerts when University of Cambridge's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free